Upcoming events on GENMAB A/S |
|
02/22/23 | 11:00am | | FY 2022 Earnings Release |
03/29/23 | | Annual General Meeting |
05/10/23 | 11:00am | | Q1 2023 Earnings Release |
08/03/23 | 11:00am | | Interim 2023 Earnings Release |
11/07/23 | 11:00am | | Q3 2023 Earnings Release |
02/21/24 | | FY 2023 Earnings Release (Projected) |
05/08/24 | | Q1 2024 Earnings Release (Projected) |
08/07/24 | | Interim 2024 Earnings Release (Projected) |
11/06/24 | | Q3 2024 Earnings Release (Projected) |
|
Past events on GENMAB A/S |
|
01/11/23 | 12:00pm | | JP Morgan Healthcare Conference |
12/13/22 | | American Society of Hematology Meeting - Abstract Number ?-4182 |
12/13/22 | | American Society of Hematology Meeting - Abstract Number ?-4206 |
12/13/22 | | American Society of Hematology Meeting - Abstract Number ?-4271 |
12/13/22 | | American Society of Hematology Meeting - Abstract Number ?-4912 |
12/13/22 | | American Society of Hematology Meeting - Abstract Number?-4251 |
12/12/22 | | American Society of Hematology Meeting - Abstract Number ?-2978 |
12/12/22 | | American Society of Hematology Meeting - Abstract Number ?-1366 |
12/12/22 | | American Society of Hematology Meeting - Abstract Number ?-3254 |
12/12/22 | | American Society of Hematology Meeting - Abstract Number ?-2874 |
|
Past dividends on GENMAB A/S |
|
- No events available -
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M DKK |
Released Forecast Spread | 2 365 2 325 1,7% | 3 025 2 905 4,1% | 5 366 5 159 4,0% | 10 111 9 843 2,7% | 8 482 8 376 1,3% | 14 089 |
Operating income (EBITDA) M DKK |
Released Forecast Spread | 1 414 1 315 7,6% | 1 468 1 431 2,6% | 2 777 2 460 13% | 6 572 6 099 7,8% | 3 266 3 111 5,0% | 6 371 |
Operating profit (EBIT) M DKK |
Released Forecast Spread | 1 344 1 250 7,5% | 1 380 1 388 -0,54% | 2 638 2 317 14% | 6 313 5 967 5,8% | 3 018 2 960 2,0% | 6 008 |
Pre-Tax Profit (EBT) M DKK |
Released Forecast Spread | 1 064 1 211 -12% | 1 612 1 512 6,6% | 2 859 2 645 8,1% | 5 904 5 723 3,2% | 3 983 3 731 6,8% | 8 905 |
Net income M DKK |
Released Forecast Spread | 1 104 1 053 4,8% | 1 472 1 281 15% | 2 166 2 085 3,9% | 4 758 4 706 1,1% | 3 008 2 847 5,6% | 6 807 |
EPS DKK |
Released Forecast Spread | 17,8 17,4 2,0% | 23,7 20,8 14% | 34,0 32,8 3,6% | 72,2 69,4 4,1% | 45,5 43,8 3,9% | 103 | Announcement Date | 02/21/2018 | 02/20/2019 | 02/19/2020 | 02/23/2021 | 02/16/2022 | - |
|
|
Fiscal Period : December | 2018 S1 | 2019 S1 | 2020 S1 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
Sales M DKK |
Released Forecast Spread | 1 191 1 147 3,8% | 1 365 1 369 -0,29% | 6 343 6 164 2,9% | 1 724 1 475 17% | 2 044 1 804 13% | 1 581 1 363 16% | 1 972 1 701 16% | 3 553 3 224 10% | 2 310 2 174 6,3% | 2 619 2 561 2,3% | 2 119 2 074 2,1% | 3 162 2 833 12% | 5 281 5 136 2,8% | 4 087 3 634 12% | 4 763 | 2 690 | 3 909 | 4 171 | 4 773 |
Operating income (EBITDA) M DKK |
Released Forecast Spread | 418 | 125 189 -34% | 4 583 4 480 2,3% | 868 549 58% | 1 121 634 77% | 543 307 77% | 802 409 96% | 1 345 980 37% | 905 698 30% | 1 016 776 31% | 529 358 48% | 1 263 1 312 -3,7% | 1 792 1 951 -8,1% | 1 953 1 583 23% | 2 708 | 654 | 1 609 | 1 512 | 1 122 |
Operating profit (EBIT) M DKK |
Released Forecast Spread | 459 392 17% | 111 116 -4,3% | 4 568 4 389 4,1% | 858 451 90% | 887 581 53% | 532 153 248% | 787 385 104% | 1 319 864 53% | 890 675 32% | 809 795 1,8% | 514 442 16% | 1 247 1 156 7,9% | 1 761 1 814 -2,9% | 1 931 1 541 25% | 2 314 | 455 | 1 539 | 1 501 | 1 611 |
Pre-Tax Profit (EBT) M DKK |
Released Forecast Spread | 591 323 83% | 205 250 -18% | 4 682 4 682 0,00% | 671 470 43% | 551 646 -15% | 1 424 129 1 004% | 422 377 12% | 1 846 1 759 4,9% | 1 171 688 70% | 966 772 25% | 612 499 23% | 2 489 1 183 110% | 3 101 1 932 61% | 3 272 1 584 107% | 2 199 | 395 | 1 479 | 1 444 | 1 566 |
Net income M DKK |
Released Forecast Spread | 459 252 82% | 157 225 -30% | 3 647 4 573 -20% | 530 380 39% | 581 484 20% | 1 096 87,8 1 149% | 306 296 3,2% | 1 402 1 372 2,2% | 890 562 58% | 716 603 19% | 465 357 30% | 1 891 913 107% | 2 356 1 469 60% | 2 582 1 187 117% | 1 595 | 303 | 1 071 | 1 130 | 1 231 |
EPS
|
Released Forecast Spread | 7,41 4,10 81% | 2,53 3,70 -32% | 55,5 70,2 -21% | 8,04 5,93 36% | 8,75 7,30 20% | 16,6 1,69 881% | 4,64 4,51 2,9% | 21,3 20,9 1,7% | 13,5 8,30 62% | 10,8 9,25 17% | 7,05 5,39 31% | 28,7 13,8 107% | 35,7 22,1 62% | 39,2 18,3 114% | 23,2 | 6,43 | 17,7 | 18,7 | 19,9 | Announcement Date | 08/08/2018 | 08/14/2019 | 08/12/2020 | 11/04/2020 | 02/23/2021 | 05/05/2021 | 08/11/2021 | 08/11/2021 | 11/10/2021 | 02/16/2022 | 05/11/2022 | 08/10/2022 | 08/10/2022 | 11/09/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for GENMAB A/S |
|
|
|
Past sector events for GENMAB A/S |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|